Literature DB >> 26690980

Bristol Stool Form Scale reliability and agreement decreases when determining Rome III stool form designations.

B P Chumpitazi1,2, M M Self1,3, D I Czyzewski1,2,3, S Cejka1, P R Swank4, R J Shulman1,2,5.   

Abstract

BACKGROUND: Rater reproducibility of the Bristol Stool Form Scale (BSFS), which categorizes stools into one of seven types, is unknown. We sought to determine reliability and agreement by individual stool type and when responses are categorized by Rome III clinical designation as normal or abnormal (constipation or diarrhea).
METHODS: Thirty-four gastroenterology providers from three institutions rated 35 stool photographs using the BSFS. Twenty rerated the photographs. KEY
RESULTS: 1190 individual stool type ratings were completed. Though only four photographs had absolute agreement (all Type 1 or Type 7), general agreement was high with 1132 (95.1%) of ratings being within one category type of the modal rating. Inter-rater and intra-rater reliability of the BSFS by individual stool type was excellent with intraclass correlations of 0.88 (95% CI: 0.86-0.90, p < 0.001) and 0.89 (95% CI: 0.86-0.91, p < 0.001), respectively. However, agreement decreased when using Rome III designations with 13 (37%) photographs having significantly diverging classifications (semi-interquartile range = 0.5). These 13 photographs were rated by the majority of raters as either type 2 vs type 3 or type 5 vs type 6 stools, representing the boundaries of normal vs abnormal stools. Inter-rater and intra-rater reliability of the BSFS by Rome III clinical categorization decreased with intraclass correlations of 0.75 (95% CI: 0.69-0.81, p < 0.001) and 0.65 (95% CI: 0.49-0.81, p < 0.001), respectively. CONCLUSIONS & INFERENCES: The Bristol Stool Form Scale has excellent reliability and agreement when used to rate individual stool type by raters. However, BSFS reliability and agreement decreases when determining Rome III stool form categories.
© 2015 John Wiley & Sons Ltd.

Entities:  

Keywords:  constipation; diarrhea; irritable bowel syndrome; stool form

Mesh:

Year:  2015        PMID: 26690980      PMCID: PMC4760857          DOI: 10.1111/nmo.12738

Source DB:  PubMed          Journal:  Neurogastroenterol Motil        ISSN: 1350-1925            Impact factor:   3.598


  22 in total

1.  Stool form scale as a useful guide to intestinal transit time.

Authors:  S J Lewis; K W Heaton
Journal:  Scand J Gastroenterol       Date:  1997-09       Impact factor: 2.423

2.  A randomized trial of 5-hydroxytryptamine4-receptor agonist, YKP10811, on colonic transit and bowel function in functional constipation.

Authors:  Andrea Shin; Andres Acosta; Michael Camilleri; Amy Boldingh; Duane Burton; Michael Ryks; Deborah Rhoten; Alan R Zinsmeister
Journal:  Clin Gastroenterol Hepatol       Date:  2014-08-19       Impact factor: 11.382

3.  How well does stool form reflect colonic transit?

Authors:  L P Degen; S F Phillips
Journal:  Gut       Date:  1996-07       Impact factor: 23.059

4.  Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior.

Authors:  D V Cicchetti; S A Sparrow
Journal:  Am J Ment Defic       Date:  1981-09

5.  Subtypes of irritable bowel syndrome in children: prevalence at diagnosis and at follow-up.

Authors:  Eleonora Giannetti; Gianluigi de'Angelis; Rossella Turco; Angelo Campanozzi; Licia Pensabene; Silvia Salvatore; Federica de Seta; Annamaria Staiano
Journal:  J Pediatr       Date:  2014-01-31       Impact factor: 4.406

Review 6.  Functional bowel disorders.

Authors:  George F Longstreth; W Grant Thompson; William D Chey; Lesley A Houghton; Fermin Mearin; Robin C Spiller
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

7.  Postoperative bowel function, symptoms, and habits in women after vaginal reconstructive surgery.

Authors:  Alicia Ballard; Candace Parker-Autry; Chee Paul Lin; Alayne D Markland; David R Ellington; Holly E Richter
Journal:  Int Urogynecol J       Date:  2015-02-12       Impact factor: 2.894

8.  Diarrhea in Crohn’s disease: investigating the role of the ileal hormone fibroblast growth factor 19.

Authors:  Jonathan D Nolan; Ian M Johnston; Sanjeev S Pattni; Tracy Dew; Timothy R Orchard; Julian R F Walters
Journal:  J Crohns Colitis       Date:  2015-02       Impact factor: 9.071

9.  The Bristol stool scale and its relationship to Clostridium difficile infection.

Authors:  Daniel A Caroff; Paul H Edelstein; Keith Hamilton; David A Pegues
Journal:  J Clin Microbiol       Date:  2014-07-16       Impact factor: 5.948

10.  A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea.

Authors:  Klara Garsed; Julia Chernova; Margaret Hastings; Ching Lam; Luca Marciani; Gulzar Singh; Amanda Henry; Ian Hall; Peter Whorwell; Robin Spiller
Journal:  Gut       Date:  2013-12-12       Impact factor: 23.059

View more
  19 in total

1.  Stooling Characteristics in Children With Irritable Bowel Syndrome.

Authors:  Erica M Weidler; Mariella M Self; Danita I Czyzewski; Robert J Shulman; Bruno P Chumpitazi
Journal:  Clin Gastroenterol Hepatol       Date:  2016-08-25       Impact factor: 11.382

2.  Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.

Authors:  Robert J Shulman; Lena Öhman; Mats Stridsberg; Kevin Cain; Magnus Simrén; Margaret Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2018-10-09       Impact factor: 3.598

Review 3.  Routine disaccharidase testing: are we there yet?

Authors:  Antone R Opekun; Bruno P Chumpitazi; Mustafa M Abdulsada; Buford L Nichols
Journal:  Curr Opin Gastroenterol       Date:  2020-03       Impact factor: 2.741

4.  Gut Microbiome Changes with Osteopathic Treatment of Constipation in Parkinson's Disease: A Pilot Study.

Authors:  Jayme D Mancini; Sheldon Yao; Luis R Martinez; Haque Shakil; To Shan Li
Journal:  Neurology (ECronicon)       Date:  2021-01-30

5.  Development of the Brussels Infant and Toddler Stool Scale ('BITSS'): protocol of the study.

Authors:  Yvan Vandenplas; Hania Szajewska; Marc Benninga; Carlo Di Lorenzo; Christophe Dupont; Christophe Faure; Mohamed Miqdadi; Seksit Osatakul; Carmen Ribes-Konickx; Miguel Saps; Raanan Shamir; Annamaria Staiano
Journal:  BMJ Open       Date:  2017-03-29       Impact factor: 2.692

6.  Fecograph: A graphical representation of daily stool forms to subtype irritable bowel syndrome in office practice.

Authors:  Chirag Shah; Anumeet S Grover; Prashant Dhore; Akash Shukla; Philip Abraham; Shobna J Bhatia
Journal:  JGH Open       Date:  2019-01-31

7.  Microbiota, type 2 diabetes and non-alcoholic fatty liver disease: protocol of an observational study.

Authors:  Benedetta M Motta; Christoph Grander; Martin Gögele; Luisa Foco; Vladimir Vukovic; Roberto Melotti; Christian Fuchsberger; Alessandro De Grandi; Chiara Cantaloni; Anne Picard; Deborah Mascalzoni; Alessandra Rossini; Cristian Pattaro; Herbert Tilg; Peter P Pramstaller
Journal:  J Transl Med       Date:  2019-12-04       Impact factor: 5.531

8.  Transcutaneous Acupoint Electrical Stimulation on Chemotherapy-Induced Constipation for Non-Small Cell Lung Cancer Patients: A Randomized Controlled Trial.

Authors:  Ting Mao; Xiangyu Liu; Qinqin Cheng; Yongyi Chen
Journal:  Asia Pac J Oncol Nurs       Date:  2021-03-12

9.  Possible pathogenicity of commensal Entamoeba hartmanni revealed by molecular screening of healthy school children in Indonesia.

Authors:  Takahiro Matsumura; Joko Hendarto; Tetsushi Mizuno; Din Syafruddin; Hisao Yoshikawa; Makoto Matsubayashi; Taro Nishimura; Masaharu Tokoro
Journal:  Trop Med Health       Date:  2019-01-15

10.  Adherence and Effects Derived from FODMAP Diet on Irritable Bowel Syndrome: A Real Life Evaluation of a Large Follow-Up Observation.

Authors:  Antonietta Gerarda Gravina; Marcello Dallio; Mario Romeo; Antonietta Di Somma; Gaetano Cotticelli; Carmelina Loguercio; Alessandro Federico
Journal:  Nutrients       Date:  2020-03-27       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.